Cargando…

Indices of sarcopenic obesity are important predictors of finite element analysis-derived bone strength in older adults with obesity

BACKGROUND: The expanding population of older adults with obesity is a public health challenge, in part, because of the increased risk of fractures despite normal or high bone mineral density. Potential factors predisposing to fractures in this group include sarcopenia associated with obesity and im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gregori, Giulia, Paudyal, Arjun, Barnouin, Yoann, Celli, Alessandra, Segoviano-Escobar, Martha Belen, Armamento-Villareal, Reina, Napoli, Nicola, Qualls, Clifford, Villareal, Dennis T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660264/ https://www.ncbi.nlm.nih.gov/pubmed/38027147 http://dx.doi.org/10.3389/fendo.2023.1279321

Ejemplares similares

Sarcopenic Obesity Indices Are Major Determinants of Bone Strength in Older Adults With Obesity
por: Gregori, Giulia, et al.
Publicado: (2021)

OR02-05 Effect of Testosterone Replacement Therapy Added to Intensive Lifestyle Intervention on Cognitive Functions in Frail, Older Veterans with Hypogonadism and Obesity: A Randomized Clinical Trial
por: Gregori, Giulia, et al.
Publicado: (2020)

SUN-541 Effect of Testosterone Replacement Therapy Added to Intensive Lifestyle Intervention in Frail, Older Male Veterans with Hypogonadism and Obesity: A Randomized Clinical Trial
por: Barnouin, Yoann, et al.
Publicado: (2020)

Weight Loss, Exercise, or Both and Cardiometabolic Risk Factors in Obese Older Adults: Results of a Randomized Controlled Trial
por: Bouchonville, Matthew, et al.
Publicado: (2013)

Fat, Muscle, and Bone Interactions in Obesity and the Metabolic Syndrome
por: Armamento-Villareal, Reina, et al.
Publicado: (2014)

MON-382 Bone Quality and Strength in Obese Men with Type 2 Diabetes Mellitus Are Impaired and Negatively Influenced by Adiposity
por: Vigevano, Francesca, et al.
Publicado: (2020)

MON-094 Aromatase Inhibitors and Weight Loss in Severely Obese Male Veterans with Hypogonadism: A Randomized Clinical Trial
por: Colleluori, Georgia, et al.
Publicado: (2019)

Effect of Weight Loss, Exercise, or Both on Undercarboxylated Osteocalcin and Insulin Secretion in Frail, Obese Older Adults
por: Colleluori, Georgia, et al.
Publicado: (2017)

Fat Mass Follows a U-Shaped Distribution Based on Estradiol Levels in Postmenopausal Women
por: Colleluori, Georgia, et al.
Publicado: (2018)

Adipocytes ESR1 Expression, Body Fat and Response to Testosterone Therapy in Hypogonadal Men Vary According to Estradiol Levels
por: Colleluori, Georgia, et al.
Publicado: (2018)

Aromatase Inhibitors Plus Weight Loss Improves the Hormonal Profile of Obese Hypogonadal Men Without Causing Major Side Effects
por: Colleluori, Georgia, et al.
Publicado: (2020)

Testosterone and Adipokines are Determinants of Physical Performance, Strength, and Aerobic Fitness in Frail, Obese, Older Adults
por: Aguirre, Lina E., et al.
Publicado: (2014)

The complex pathophysiology of bone fragility in obesity and type 2 diabetes mellitus: therapeutic targets to promote osteogenesis
por: Bathina, Siresha, et al.
Publicado: (2023)

Testosterone therapy and bone quality in men with diabetes and hypogonadism: Study design and protocol
por: Russo, Vittoria, et al.
Publicado: (2021)

Baseline Testosterone Predicts Body Composition and Metabolic Response to Testosterone Therapy
por: Deepika, FNU, et al.
Publicado: (2022)

Circulating osteogenic progenitors and osteoclast precursors are associated with long-term glycemic control, sex steroids, and visceral adipose tissue in men with type 2 diabetes mellitus
por: Ballato, Elliot, et al.
Publicado: (2022)

ODP101 In Men with Type 2 Diabetes Mellitus, Poor Glycemic Control is Associated with Diminished Circulating Osteoblast Progenitors
por: Ballato, Elliot, et al.
Publicado: (2022)

OR25-6 In Men on Testosterone Therapy, Baseline Testosterone Level of <264 ng/dL is Associated with Greater Improvement in Body Composition, While Level of ≥264 ng/dL Favors Improvement in Metabolic Profile
por: Aguirre, Lina, et al.
Publicado: (2022)

Hemoglobin A1c Threshold for Reduction in Bone Turnover in Men With Type 2 Diabetes Mellitus
por: Joad, Sabaa, et al.
Publicado: (2021)

The rs4646 and rs12592697 Polymorphisms in CYP19A1 Are Associated with Disease Progression among Patients with Breast Cancer from Different Racial/Ethnic Backgrounds
por: Armamento-Villareal, Reina, et al.
Publicado: (2016)

Hypogonadism, Type-2 Diabetes Mellitus, and Bone Health: A Narrative Review
por: Russo, Vittoria, et al.
Publicado: (2021)

Novel Adipokines and Their Role in Bone Metabolism: A Narrative Review
por: Deepika, Fnu, et al.
Publicado: (2023)

Sarcopenic osteoporosis, sarcopenic obesity, and sarcopenic osteoporotic obesity in the Camargo cohort (Cantabria, Spain)
por: Hernández-Martínez, Paula, et al.
Publicado: (2022)

Hemoglobin A1c of 7% is the Threshold For Bone Impairment in Men With Type 2 Diabetes Mellitus
por: Joad, Sabaa Salim, et al.
Publicado: (2021)

Sarcopenia and Sarcopenic Obesity
por: Choi, Kyung Mook
Publicado: (2013)

Sarcopenia and sarcopenic obesity
por: Choi, Kyung Mook
Publicado: (2016)

SUN-LB69 A Comparison Between Weight Loss Associated Bone Loss From Lifestyle Measures Versus Bariatric Surgery
por: La, Betty, et al.
Publicado: (2020)

Using relative handgrip strength to identify children at risk of sarcopenic obesity
por: Steffl, Michal, et al.
Publicado: (2017)

Sarcopenic obesity and cognitive performance
por: Tolea, Magdalena I, et al.
Publicado: (2018)

OR27-01 Upregulated Prdm16 Impairs Adipogenesis And Promotes Myogenesis Via PAX7 And Osteogenesis In Testosterone-treated Hypogonadal Men
por: Bathina, Siresha, et al.
Publicado: (2023)

Sarcopenic Obesity and Endocrinal Adaptation with Age
por: Sakuma, Kunihiro, et al.
Publicado: (2013)

Prevention and Treatment of Sarcopenic Obesity in Women
por: Petroni, Maria L., et al.
Publicado: (2019)

Sarcopenic obesity: time to target the phenotypes
por: Perna, Simone, et al.
Publicado: (2019)

Sarcopenic Obesity in Facioscapulohumeral Muscular Dystrophy
por: Vera, Kathryn, et al.
Publicado: (2020)

CONTROVERSIES AND CHALLENGES IN DEFINING SARCOPENIC OBESITY
por: Batsis, John A
Publicado: (2019)

The Ketogenic Diet: Is It an Answer for Sarcopenic Obesity?
por: Ilyas, Zahra, et al.
Publicado: (2022)

Editorial: Sarcopenic Obesity: Mechanisms and Countermeasures
por: Murton, Andrew J., et al.
Publicado: (2022)

Impact of sarcopenic obesity on functional outcomes
por: Shimizu, Akio, et al.
Publicado: (2023)

Editorial: (Osteo)Sarcopenia & sarcopenic obesity
por: Masiero, Stefano, et al.
Publicado: (2023)

The impact of sarcopenic obesity on inflammation, lean body mass, and muscle strength in elderly women
por: Nascimento, Dahan da Cunha, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8t8kiobiqi7s45cmfe9hv84l6v